Correlation Between Milestone Pharmaceuticals and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Protara Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Protara Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Protara Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and Protara is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Protara Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 2.33 times less return on investment than Protara Therapeutics. But when comparing it to its historical volatility, Milestone Pharmaceuticals is 1.4 times less risky than Protara Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Protara Therapeutics is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Protara Therapeutics on August 29, 2024 and sell it today you would earn a total of 111.00 from holding Protara Therapeutics or generate 60.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 97.67% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Protara Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Protara Therapeutics |
Milestone Pharmaceuticals and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Protara Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |